ES8301220A1 - Procedimiento para la preparacion de derivados de imidazol - Google Patents

Procedimiento para la preparacion de derivados de imidazol

Info

Publication number
ES8301220A1
ES8301220A1 ES503678A ES503678A ES8301220A1 ES 8301220 A1 ES8301220 A1 ES 8301220A1 ES 503678 A ES503678 A ES 503678A ES 503678 A ES503678 A ES 503678A ES 8301220 A1 ES8301220 A1 ES 8301220A1
Authority
ES
Spain
Prior art keywords
groups
optionally substituted
residues
alkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES503678A
Other languages
English (en)
Other versions
ES503678A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES8301220A1 publication Critical patent/ES8301220A1/es
Publication of ES503678A0 publication Critical patent/ES503678A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE IMIDAZOL, DE FORMULA GENERAL (I), EN DONDE AR Y AR SIGNIFICAN UN RADICAL FENILO EVENTUALMENTE SUSTITUIDO CON ATOMOS DE HALOGENO, CON RADICALES ALCOHILO O CON RADICALES ALCOXI, O UN RADICAL FURILO O UN RADICAL TIENILO; R SIGNIFICA HIDROGENO O UN RADICAL ALCOHILO; N PUEDE SER 0, 1 O 2; Y Z SIGNIFICA UN RADICAL FENILO EVENTUALMENTE SUSTITUIDO CON ATOMOS DE HALOGENO, CON GRUPOS ALCOHILO, CON GRUPOS ALCOXI O CON GRUPOS NITRO; Y SUS SALES DE ACIDO FISIOLOGICAMENTE INOCUAS. CONSISTE EN CONDENSAR UN COMPUESTO DE FORMULA GENERAL (II), EN DONDE AR , AR Y R TIENEN LOS SIGNIFICADOS YA INDICADOS, CON UN COMPUEST DE FORMULA GENERAL (III), EN DONDE Z TIENE EL SIGNIFICADO YA INDICADO >DE APLICACION EN FARMACIA POR SU ACTIVIDAD ANTIINFLAMATORIA Y ANTIALERGICA.
ES503678A 1980-07-03 1981-07-03 Procedimiento para la preparacion de derivados de imidazol Granted ES503678A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803025484 DE3025484A1 (de) 1980-07-03 1980-07-03 Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
ES8301220A1 true ES8301220A1 (es) 1982-12-01
ES503678A0 ES503678A0 (es) 1982-12-01

Family

ID=6106465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503678A Granted ES503678A0 (es) 1980-07-03 1981-07-03 Procedimiento para la preparacion de derivados de imidazol

Country Status (17)

Country Link
US (2) US4402960A (es)
EP (1) EP0043788B1 (es)
JP (1) JPS5775973A (es)
AT (1) ATE16281T1 (es)
AU (1) AU7249481A (es)
CA (1) CA1169063A (es)
DD (1) DD206152A5 (es)
DE (2) DE3025484A1 (es)
DK (1) DK293381A (es)
ES (1) ES503678A0 (es)
FI (1) FI812106L (es)
GR (1) GR78231B (es)
IE (1) IE52822B1 (es)
IL (1) IL63190A0 (es)
NO (1) NO812265L (es)
PT (1) PT73280B (es)
ZA (1) ZA814540B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3141063A1 (de) * 1981-10-13 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US5300519A (en) * 1988-07-06 1994-04-05 The University Of Sheffield Immunosuppressive agents
JP2614756B2 (ja) * 1988-08-10 1997-05-28 日本ケミファ株式会社 イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
CA2003283A1 (en) * 1988-12-05 1990-06-05 C. Anne Higley Imidazoles for the treatment of atherosclerosis
GB8907656D0 (en) * 1989-04-05 1989-05-17 May & Baker Ltd New compositions of matter
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
GB9005966D0 (en) * 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US6040320A (en) * 1997-06-30 2000-03-21 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de) 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) * 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
EP1894925A1 (en) * 2006-08-24 2008-03-05 Merckle Gmbh Imidazole compounds having an antiinflammatory effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6614808A (es) * 1965-10-21 1967-04-24
US3651080A (en) * 1969-11-07 1972-03-21 Ciba Geigy Corp Certain substituted 2-alkylmercaptoimidazole derivatives
US4190666A (en) * 1975-08-11 1980-02-26 E. I. Du Pont De Nemours And Company Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones
US4215217A (en) * 1975-10-29 1980-07-29 Sk&F Lab Co. Process for preparing 4-substituted imidazole compounds
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
DE2963572D1 (en) * 1978-04-11 1982-10-21 Ciba Geigy Ag Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
DE2960506D1 (en) * 1978-04-24 1981-10-29 Dumex Ltd As Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4330552A (en) * 1980-11-06 1982-05-18 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-2-arylthioimidazoles

Also Published As

Publication number Publication date
EP0043788A1 (de) 1982-01-13
DD206152A5 (de) 1984-01-18
DE3172757D1 (en) 1985-12-05
IE811484L (en) 1982-01-03
GR78231B (es) 1984-09-26
PT73280A (de) 1981-07-01
JPH0254343B2 (es) 1990-11-21
US4402960A (en) 1983-09-06
ES503678A0 (es) 1982-12-01
JPS5775973A (en) 1982-05-12
AU7249481A (en) 1982-01-07
PT73280B (de) 1982-07-22
DE3025484A1 (de) 1982-02-04
EP0043788B1 (de) 1985-10-30
IE52822B1 (en) 1988-03-16
IL63190A0 (en) 1981-09-13
US4528298A (en) 1985-07-09
CA1169063A (en) 1984-06-12
NO812265L (no) 1982-01-04
DK293381A (da) 1982-01-04
ATE16281T1 (de) 1985-11-15
ZA814540B (en) 1982-07-28
FI812106L (fi) 1982-01-04

Similar Documents

Publication Publication Date Title
NO822183L (no) Fremgangsmaate for fremstilling av substituerte imidazolderivater
ES8301220A1 (es) Procedimiento para la preparacion de derivados de imidazol
ES8104321A1 (es) Procedimiento para separar un derivado de alquil-cetohexopi-ranosida
ES8503339A1 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
DE2967513D1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions containing them
FR2398065A1 (es)
FR2386544A1 (fr) Procede pour la preparation de derives d'imidazodiazepine
ES8403877A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
YU217181A (en) Process for preparing 2-(1,4-benzodioxane-2-ylalkyl)-imidazoles
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
FR2398736A1 (fr) Derives a-halogenomethyles d'aminoacides, leur procede de preparation et leur utilisation comme antiallergiques
HUT49326A (en) Process for producing sulfon derivatives as hydroxyalkilating agents
ES540260A0 (es) Procedimiento para preparar derivados de 2-alcoxiaminosulfo-nilbencenosulfonilurea
ES8702399A1 (es) Un procedimiento para preparar derivdos de 1,5-benzoxatiepina
FR2379523A1 (fr) Procede de preparation de derives de l'indoline
ES470977A1 (es) Un procedimiento para la preparacion del compuesto 2-(gamma-(1-piperidinil)propil)-1,2-benzisotiazol-3-ona
ES8204729A1 (es) Procedimiento para la preparacion de acidos de 2-(3'-tienil)propionicos 5'-sustituidos
FR2354323A1 (fr) Derives de l'hydrazinopyridazine et leur application pharmacologique
FR2442838A1 (fr) Procede de preparation de mercapto-5 triazoles-1,2,3
ES8507513A1 (es) Un procedimiento para preparar derivados bis-dioxopiperazinicos
ES483303A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
FR2390956A1 (fr) Derives substitues de la quinolizidine et de l'indolizidine, leur procede de preparation et agents therapeutiques contenant lesdits derives
FR2406636A1 (fr) Procede de preparation de 2,5-dialkyl-4-hydroxy-2,3-dihydrofuran-3-ones
ES456093A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-tiazolinil bencimidazoles 5(6)-sustituidos.